Amy Schunemeyer, DPM
Foot & Ankle Surgery · New Iberia, LANPI 1285629451
Payments from drug & device makers
Across 29 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$87
- Paratek Pharmaceuticals, Inc.$87
- Stryker$82
- Merck$47
- Pfizer$43
- Philips North America LLC$39
- plus $147 from 7 others
What the payments were for
- Food & beverage$533100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $87 |
| Paratek Pharmaceuticals, Inc. | 5 | $87 |
| Stryker | 2 | $82 |
| Merck | 3 | $47 |
| Pfizer | 3 | $43 |
| Philips North America LLC | 1 | $39 |
| Nevro Corp. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $21 |
| AbbVie | 1 | $16 |
| Organogenesis Inc. | 1 | $15 |
| Trice Medical, Inc. | 1 | $12 |
How this compares
$533 in reported general payments places this provider in the 25th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 395 | $6,999 |
| Pregabalin | 220 | $5,996 |
| Febuxostat | 78 | $5,875 |
| CiclopiroxCiclopirox Olamine | 98 | $2,378 |
| Doxycycline Monohydrate | 162 | $2,279 |
| Terbinafine Hcl | 104 | $2,210 |
| Linezolid | 16 | $1,504 |
| Duloxetine Hcl | 71 | $1,127 |
| Mupirocin | 161 | $1,121 |
| Rifampin | 11 | $757 |
| Tramadol Hcl | 86 | $701 |
| Amitriptyline Hcl | 30 | $609 |
| Gentamicin Sulfate | 12 | $530 |
| Allopurinol | 62 | $485 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 31 | $465 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in New Iberia
- Brian BensonLeesville$287K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
- Leon WatkinsMetairie$18K
- Phuoc BuiMinden$15K
- Henrique HilarioShreveport$14K
- Beau WillisMetairie$13K
- Nimish ChokshiMetairie$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.